The Drugs of Abuse Testing market size is USD 6.8 Bn in 2026.
The market is projected to grow at a CAGR of 12% and reach USD 14.66 Bn by 2033.
The market growth drivers include rising illicit drug consumption, strict government regulations, and increasing workplace drug testing.
North America is a dominating region for the Drugs of Abuse Testing market.
Abbott Diagnostics, Agilent Technologies, Bio-Rad Laboratories, Danaher Corp., and Acon Laboratories Inc. are some leading industry players in the market.